Nurse Practitioner, Family · West Palm Beach, FL
NPI
1184950404
Since 2009
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2247 Palm Beach Lakes Blvd Ste 209
West Palm Beach, FL, 33409
Phone (561) 249-2279
Groups this clinician bills Medicare through
Medicare paid, 2022
$2,700
77 services
Medicare patients, 2022
16
Average age 64
Drug cost, 2024
$2.1M
932 prescriptions
Company payments, 2025
$28K
From 9 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by Jennifer L Kuretski was code 36415 (venipuncture blood collection), 24 times for 11 patients. In total Jennifer L Kuretski billed 77 services in 13 codes, and Medicare paid $2,700.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 24 | 11 | $2.96 | $70.95 |
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 24 | 11 | $2.96 | $70.95 |
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer L Kuretski prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 194 prescriptions and refills. In total Jennifer L Kuretski wrote 932 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 194 | 202 | 20 | $831K |
| Descovy Emtricitabine/Tenofov Alafenam | 95 | 101 | Under 11 | $235K |
| Valacyclovir Valacyclovir Hcl | 38 | 57 | Under 11 | $1,651 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 38 | 38 | Under 11 | $181K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 34 | 34 | Under 11 | $131K |
| Prezcobix Darunavir/Cobicistat | 32 | 32 | Under 11 | $77K |
| Cabenuva Cabotegravir/Rilpivirine | 31 | 42 | Under 11 | $196K |
| Dovato Dolutegravir Sodium/Lamivudine | 29 | 29 | Under 11 | $85K |
| Meloxicam Generic | 24 | 28 | Under 11 | $68.04 |
| Apretude Cabotegravir | 21 | 38 | Under 11 | $80K |
| Juluca Dolutegravir/Rilpivirine | 20 | 20 | Under 11 | $68K |
| Tivicay Dolutegravir Sodium | 18 | 18 | Under 11 | $67K |
| Amlodipine Besylate Generic | 16 | 30 | Under 11 | $44.57 |
| Isentress Raltegravir Potassium | 13 | 13 | Under 11 | $26K |
| Rosuvastatin Calcium Generic | 13 | 38 | Under 11 | $82.05 |
Brand drugs: 595 claims; generic drugs: 337 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer L Kuretski $28K ($28K in general payments such as food, travel and fees) from 9 companies. The largest payer was ViiV Healthcare Company with $15K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.